BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23991244)

  • 1. Mycetoma herbal treatment: the Mycetoma Research Centre, Sudan experience.
    Ezaldeen EA; Fahal AH; Osman A
    PLoS Negl Trop Dis; 2013; 7(8):e2400. PubMed ID: 23991244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hand Mycetoma: The Mycetoma Research Centre Experience and Literature Review.
    Omer RF; Seif El Din N; Abdel Rahim FA; Fahal AH
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004886. PubMed ID: 27483367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological observations and management challenges in extrapedal mycetoma: A three-decade review of 420 cases.
    Alhaj AAM; Ahmed ES; Hassan A; Fahal AH
    PLoS Negl Trop Dis; 2024 May; 18(5):e0011841. PubMed ID: 38728359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nutritional status of mycetoma affected patients seen at the Mycetoma Research Center, Sudan.
    Gabani MH; Ahmed AA; Hassan AA; Abdalla MA; Mustafa SA; Alobaid TA; Khatir AA; Mohammed RM; Awad NI; Abdellateef TA; Hassan A; Ahmed ES; Ali MZ; Fahal AH
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011726. PubMed ID: 38166142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study.
    Djuv A; Nilsen OG; Steinsbekk A
    BMC Complement Altern Med; 2013 Oct; 13():295. PubMed ID: 24171723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A holistic approach to the mycetoma management.
    Bakhiet SM; Fahal AH; Musa AM; Mohamed ESW; Omer RF; Ahmed ES; El Nour M; Mustafa ERM; Sheikh A Rahman ME; Suliman SH; El Mamoun MAG; El Amin HM
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006391. PubMed ID: 29746460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-based study on the use of herbal medicine in patients with coronary artery disease in Jordan.
    Omeish AF; Abbadi W; Ghanma IM; Drabaa Z; Botoosh FA; Seif A; Massadeh M
    J Pak Med Assoc; 2011 Jul; 61(7):683-7. PubMed ID: 22204246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of socioeconomic factors in developing mycetoma: Results from a household survey in Sennar State, Sudan.
    Hounsome N; Hassan R; Bakhiet SM; Deribe K; Bremner S; Fahal AH; Newport MJ
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010817. PubMed ID: 36251732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Surgical Treatment of Mycetoma.
    Suleiman SH; Wadaella el S; Fahal AH
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004690. PubMed ID: 27336736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the Sudan armed conflict on Mycetoma control.
    Badri R; Fahal AH
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011783. PubMed ID: 38060462
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical epidemiological characteristics of mycetoma in Eastern Sennar locality, Sennar State, Sudan.
    Hassan R; Deribe K; Fahal AH; Newport M; Bakhiet S
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009847. PubMed ID: 34898611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of traditional medicines among mycetoma patients.
    Kunna E; Yamamoto T; Fahal A
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):297-306. PubMed ID: 33247308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects.
    Elkheir LYM; Haroun R; Mohamed MA; Fahal AH
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008307. PubMed ID: 32853199
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018.
    Sow D; Ndiaye M; Sarr L; Kanté MD; Ly F; Dioussé P; Faye BT; Gaye AM; Sokhna C; Ranque S; Faye B
    PLoS One; 2020; 15(4):e0231871. PubMed ID: 32330155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review.
    James PB; Wardle J; Steel A; Adams J
    BMJ Glob Health; 2018; 3(5):e000895. PubMed ID: 30483405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycetoma in the Togolese: An Update from a Single-Center Experience.
    Darré T; Saka B; Mouhari-Toure A; Tchaou M; Dorkenoo AM; Doh K; Walla A; Amégbor K; Pitché VP; Napo-Koura G
    Mycopathologia; 2018 Dec; 183(6):961-965. PubMed ID: 29557534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of (1→3)-β-d-Glucan in Eumycetoma Patients.
    Fahal AH; Finkelman MA; Zhang Y; van de Sande WW
    J Clin Microbiol; 2016 Oct; 54(10):2614-7. PubMed ID: 27440815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.
    Elfadil H; Fahal A; Kloezen W; Ahmed EM; van de Sande W
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003488. PubMed ID: 25768115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling.
    Samy AM; van de Sande WW; Fahal AH; Peterson AT
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3250. PubMed ID: 25330098
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.